Kenya study tests simpler HIV drug switch for seniors
NCT ID NCT06444620
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether older adults (60+) living with HIV in Kenya can safely switch from their current three-drug pill to a simpler two-drug pill called DTG/3TC. About 240 participants who are already stable on treatment will be followed for 96 weeks. The main goal is to see if the new pill keeps the virus under control just as well.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DTG/3TC (dolutegravir and lamivudine combination pill)
What this could lead to
If successful, this could show that switching to a simpler two-drug pill is a safe and effective option for older adults living with HIV.
What could go wrong
This is a single-arm, open-label study with no comparison group, so results may be less reliable. It only includes people already stable on another treatment, so findings may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jaramogi Oginga Odinga Teaching and Referral Hospital
Kisumu, Kenya
-
Kenyatta National Hospital
Nairobi, Kenya